Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 179,516	$ 145,924
Marketable investments	0	171,390
Accounts receivable, net of allowance for credit losses of $7,985 and $2,497, respectively	49,829	45,562
Inventories, net	61,847	63,628
Other current assets and prepaid expenses	19,415	24,036
Restricted cash	700	700
Total current assets	311,307	451,240
Property and equipment, net	69,923	40,368
Deferred tax assets	528	590
Goodwill	1,339	1,339
Operating lease right-of-use assets	10,690	12,831
Other long-term assets	12,846	14,620
Total assets	406,633	520,988
Current liabilities:
Accounts payable	31,373	33,736
Accrued liabilities	47,043	57,452
Operating lease liabilities	2,511	2,810
Deferred revenue	11,479	11,841
Total current liabilities	92,406	105,839
Deferred revenue, net of current portion	1,629	1,657
Operating lease liabilities, net of current portion	9,466	11,352
Convertible notes, net of unamortized debt issuance costs of $10,996 and $12,666, respectively	418,129	416,459
Other long-term liabilities	1,088	862
Total liabilities	522,718	536,169
Commitments and contingencies
Stockholders’ deficit:
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 19,948,803 and 19,668,603 shares at September 30, 2023 and December 31, 2022, respectively	20	20
Additional paid-in capital	130,008	125,406
Accumulated other comprehensive income (loss)	0	(94)
Accumulated deficit	(246,113)	(140,513)
Total stockholders’ deficit	(116,085)	(15,181)
Total liabilities and stockholders’ deficit	$ 406,633	$ 520,988